Cell-free Assays (IC50/Ki) for GSK1349572 (Dolutegravir)
| Key Target | IC50 (Cell-free) | Description | Reference |
|---|---|---|---|
| GSK-3β | < 500 nM | Machine learning (Random Forest regression model) prediction of pIC₅₀ values, then transformed to IC₅₀. | PMC12756328 |
| Recombinant human MMP-1 | 83.93 µM | Fluorometric substrate assay, four-parameter curve fit using R software package. | Download PDF |
| Recombinant human MMP-2 | 16.89 µM | Fluorometric substrate assay, four-parameter curve fit using R software package. | Download PDF |
| Recombinant human MMP-3 | 60.30 µM | Fluorometric substrate assay, four-parameter curve fit using R software package. | Download PDF |
| Recombinant human MMP-7 | 308.76 µM | Fluorometric substrate assay, four-parameter curve fit using R software package. | Download PDF |
| Recombinant human MMP-8 | 12.08 µM | Fluorometric substrate assay, four-parameter curve fit using R software package. | Download PDF |
| Recombinant human MMP-9 | 11.05 µM | Fluorometric substrate assay, four-parameter curve fit using R software package. | Download PDF |
| Recombinant human MMP-12 | 131.37 µM | Fluorometric substrate assay, four-parameter curve fit using R software package. | Download PDF |
| Recombinant human MMP-13 | 36.53 µM | Fluorometric substrate assay, four-parameter curve fit using R software package. | Download PDF |
| Recombinant human MMP-14 | 10.52 µM | Fluorometric substrate assay, four-parameter curve fit using R software package. | Download PDF |
| Recombinant human MMP-19 | 54.0 µM | Fluorometric substrate assay, four-parameter curve fit using R software package. | Download PDF |
Cell-based Assay (IC50) for GSK1349572 (Dolutegravir)
| Cell Type | IC50 (Cell-based) | Description | Reference |
|---|---|---|---|
| HMrSV5 peritoneal mesothelial cells | 5.277 μM | Cell Counting Kit-8 (CCK-8) assay, dose-response curve fitting | Download PDF |
| Vero-E6 cells | 20.48 µMol | crystal violet staining mechanism to assess the cytotoxicity concentration (CC50), half maximal inhibitory concentration (IC50), and selectivity safety index (SI = CC50/IC50). | Download PDF |
| TZM-bl cells | 0.4 nM | Phenotypic susceptibility tests using serial dilutions, relative fluorescence units measured on an Infinite 200 PRO plate reader, normalized and plotted against log-transformed drug concentrations, and half-maximal inhibitory concentrations (IC50) calcula | Download PDF |
| TZM-bl cells | 0.1 nM | Phenotypic susceptibility tests using serial dilutions, relative fluorescence units measured on an Infinite 200 PRO plate reader, normalized and plotted against log-transformed drug concentrations, and half-maximal inhibitory concentrations (IC50) calcula | Download PDF |
| TZM-bl cells | 11.2 nM | Phenotypic susceptibility tests using serial dilutions, relative fluorescence units measured on an Infinite 200 PRO plate reader, normalized and plotted against log-transformed drug concentrations, and half-maximal inhibitory concentrations (IC50) calcula | Download PDF |
| TZM-bl cells | 292 nM | Phenotypic susceptibility tests using serial dilutions, relative fluorescence units measured on an Infinite 200 PRO plate reader, normalized and plotted against log-transformed drug concentrations, and half-maximal inhibitory concentrations (IC50) calcula | Download PDF |
| HIV-infected cells | 0.2 ng/mL | in vitro assay | Download PDF |
| MDM | 2.4 nM | HIV-1 reverse transcriptase (RT) activity in culture supernatants | Download PDF |
| primary HIV-1 isolates grown in CBMCs | 0.25 ± 0.25 nM | cell-based in vitro assay; RT activity; 50% effective concentrations calculated on dose–response curves using GraphPad Prism version 6.07 software. | Download PDF |
| primary human peripheral blood mononuclear cells | 89 nM | single-round infection assays | Download PDF |
| MDM | 56.7 nM | HIV-1 RT inhibition assay | Download PDF |
Check the
GSK1349572 (Dolutegravir)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Jump to
- GSK1349572 (Dolutegravir) Mechanism of Action: HIV-1 Integrase Inhibition in CD4+ T Cell Research
- GSK1349572 (Dolutegravir) Clinical Trials
- GSK1349572 (Dolutegravir) Working Concentration | Cell Culture | Treatment
- GSK1349572 (Dolutegravir) Solubility in DMSO
- GSK1349572 (Dolutegravir) Stock Solution
- GSK1349572 (Dolutegravir) Storage
- GSK1349572 (Dolutegravir) Stability
- GSK1349572 (Dolutegravir) Combination Database
- GSK1349572 (Dolutegravir) Molecular Weight
- GSK1349572 (Dolutegravir) SMILES
- GSK1349572 (Dolutegravir) CAS Number
- GSK1349572 (Dolutegravir) Chemical Structure (2D and 3D)
- GSK1349572 (Dolutegravir) Sigma (SBR00080)? Try a better option.
- GSK1349572 (Dolutegravir) MedChemExpress (HY-13238)? Try a better option.
- GSK1349572 (Dolutegravir) Cayman (22191)? Try a better option.
- GSK1349572 (Dolutegravir) APExBIO (A4074)? Try a better option.
- GSK1349572 (Dolutegravir) SDS|MSDS